In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum

Mónica Azor, Josepa Gené, Josep Cano, Deanna A. Sutton, Annette W. Fothergill, Michael G. Rinaldi, Josep Guarro

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the β-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.

Original languageEnglish (US)
Pages (from-to)2228-2231
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume52
Issue number6
DOIs
StatePublished - Jun 2008

Fingerprint

terbinafine
Fusarium
Tubulin
Pharmaceutical Preparations
Genes
In Vitro Techniques
posaconazole

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. / Azor, Mónica; Gené, Josepa; Cano, Josep; Sutton, Deanna A.; Fothergill, Annette W.; Rinaldi, Michael G.; Guarro, Josep.

In: Antimicrobial Agents and Chemotherapy, Vol. 52, No. 6, 06.2008, p. 2228-2231.

Research output: Contribution to journalArticle

Azor, Mónica ; Gené, Josepa ; Cano, Josep ; Sutton, Deanna A. ; Fothergill, Annette W. ; Rinaldi, Michael G. ; Guarro, Josep. / In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. In: Antimicrobial Agents and Chemotherapy. 2008 ; Vol. 52, No. 6. pp. 2228-2231.
@article{c807f55b906443f29ae3ae070e7e29da,
title = "In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum",
abstract = "A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the β-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.",
author = "M{\'o}nica Azor and Josepa Gen{\'e} and Josep Cano and Sutton, {Deanna A.} and Fothergill, {Annette W.} and Rinaldi, {Michael G.} and Josep Guarro",
year = "2008",
month = "6",
doi = "10.1128/AAC.00176-08",
language = "English (US)",
volume = "52",
pages = "2228--2231",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum

AU - Azor, Mónica

AU - Gené, Josepa

AU - Cano, Josep

AU - Sutton, Deanna A.

AU - Fothergill, Annette W.

AU - Rinaldi, Michael G.

AU - Guarro, Josep

PY - 2008/6

Y1 - 2008/6

N2 - A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the β-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.

AB - A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the β-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.

UR - http://www.scopus.com/inward/record.url?scp=44449086826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449086826&partnerID=8YFLogxK

U2 - 10.1128/AAC.00176-08

DO - 10.1128/AAC.00176-08

M3 - Article

C2 - 18391027

AN - SCOPUS:44449086826

VL - 52

SP - 2228

EP - 2231

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

ER -